Search research articles
Contact Us
Filters
Showing results (121-130 of 139) with videos related to
Page
of 14
Sort By:
The New England Journal of Medicine
|
November 9, 2021
Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age
Emmanuel B Walter, Kawsar R Talaat, Charu Sabharwal, et al.
Epidemics
|
January 17, 2026
Estimating influenza transmission parameters: Comparing two study designs, 2023-2024
Jessica E Biddle, Stacey House, Jennie H Kwon, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 10, 2020
SARS-CoV-2 Infections Among Children in the Biospecimens from Respiratory Virus-Exposed Kids (BRAVE Kids) Study
Jillian H Hurst, Sarah M Heston, Hailey N Chambers, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 3, 2020
Severe Acute Respiratory Syndrome Coronavirus 2 Infections Among Children in the Biospecimens from Respiratory Virus-Exposed Kids (BRAVE Kids) Study
Jillian H Hurst, Sarah M Heston, Hailey N Chambers, et al.
Nature Communications
|
November 30, 2023
Engineered immunogens to elicit antibodies against conserved coronavirus epitopes
A Brenda Kapingidza, Daniel J Marston, Caitlin Harris, et al.
Biorxiv : the Preprint Server for Biology
|
March 13, 2023
Engineered Immunogens to Elicit Antibodies Against Conserved Coronavirus Epitopes
Brenda Kapingidza, Daniel J Marston, Caitlin Harris, et al.
The New England Journal of Medicine
|
February 15, 2023
Evaluation of BNT162b2 Covid-19 Vaccine in Children Younger than 5 Years of Age
Flor M Muñoz, Lawrence D Sher, Charu Sabharwal, et al.
Plos One
|
November 1, 2011
H3N2 influenza infection elicits more cross-reactive and less clonally expanded anti-hemagglutinin antibodies than influenza vaccination
M Anthony Moody, Ruijun Zhang, Emmanuel B Walter, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 10, 2023
Immunogenicity of the BA.1 and BA.4/BA.5 Severe Acute Respiratory Syndrome Coronavirus 2 Bivalent Boosts: Preliminary Results From the COVAIL Randomized Clinical Trial
Angela R Branche, Nadine G Rouphael, Cecilia Losada, et al.
The Lancet. Infectious Diseases
|
October 22, 2019
Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial
David I Bernstein, Jeffrey Guptill, Abdollah Naficy, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 139) with videos related to
Sort By:
Page
of 14
The New England Journal of Medicine
|
November 9, 2021
Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age
Emmanuel B Walter, Kawsar R Talaat, Charu Sabharwal, et al.
Epidemics
|
January 17, 2026
Estimating influenza transmission parameters: Comparing two study designs, 2023-2024
Jessica E Biddle, Stacey House, Jennie H Kwon, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 10, 2020
SARS-CoV-2 Infections Among Children in the Biospecimens from Respiratory Virus-Exposed Kids (BRAVE Kids) Study
Jillian H Hurst, Sarah M Heston, Hailey N Chambers, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 3, 2020
Severe Acute Respiratory Syndrome Coronavirus 2 Infections Among Children in the Biospecimens from Respiratory Virus-Exposed Kids (BRAVE Kids) Study
Jillian H Hurst, Sarah M Heston, Hailey N Chambers, et al.
Nature Communications
|
November 30, 2023
Engineered immunogens to elicit antibodies against conserved coronavirus epitopes
A Brenda Kapingidza, Daniel J Marston, Caitlin Harris, et al.
Biorxiv : the Preprint Server for Biology
|
March 13, 2023
Engineered Immunogens to Elicit Antibodies Against Conserved Coronavirus Epitopes
Brenda Kapingidza, Daniel J Marston, Caitlin Harris, et al.
The New England Journal of Medicine
|
February 15, 2023
Evaluation of BNT162b2 Covid-19 Vaccine in Children Younger than 5 Years of Age
Flor M Muñoz, Lawrence D Sher, Charu Sabharwal, et al.
Plos One
|
November 1, 2011
H3N2 influenza infection elicits more cross-reactive and less clonally expanded anti-hemagglutinin antibodies than influenza vaccination
M Anthony Moody, Ruijun Zhang, Emmanuel B Walter, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 10, 2023
Immunogenicity of the BA.1 and BA.4/BA.5 Severe Acute Respiratory Syndrome Coronavirus 2 Bivalent Boosts: Preliminary Results From the COVAIL Randomized Clinical Trial
Angela R Branche, Nadine G Rouphael, Cecilia Losada, et al.
The Lancet. Infectious Diseases
|
October 22, 2019
Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial
David I Bernstein, Jeffrey Guptill, Abdollah Naficy, et al.
Page
of 14